☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Eosinophil-Driven Diseases
GSK's Nucala (mepolizumab) Receives the EC's Approval for the Treatment of Eosinophil-Driven Diseases
November 18, 2021
Insights+: The US FDA New Drug Approvals in October 2021
November 18, 2021
Load more...
Back to Home
